アリピプラゾール(エビリファイ)はアカシジアは出やすいが太りにくい ブレクスピプラゾール(レキサルティ)は太りやすいがアカシジアは出にくい 増強療法は 基本的には後発品があるアリピプラゾールを選択することが多いです https://t.co/VzAhgTNw6R
[Full text] Clinical role of brexpiprazole in depression and schizophrenia | TCRM https://t.co/oeZndVsx8K
[Full text] Clinical role of brexpiprazole in depression and schizophrenia | TCRM... https://t.co/tDKsQ2GYYG
RT @Dra_TeraizaMesa: Clinical role of brexpiprazole in depression and schizophrenia The approval of brexpiprazole in 2015 marks the arrival…
Clinical role of brexpiprazole in depression and schizophrenia The approval of brexpiprazole in 2015 marks the arrival of the second D2 partial agonist to market for the primary treatment of schizophrenia and adjunctive therapy for MDD https://t.co/Uvabwsa
Clinical role of brexpiprazole in depression and schizophrenia. - PubMed - NCBI https://t.co/jaCYVurbuW
Clinical role of brexpiprazole in depression and schizophrenia. - PubMed - NCBI https://t.co/ZpmpfT2IRD
[schizo] Clinical role of brexpiprazole in depression and schizophrenia. https://t.co/LeE97FOGgO
New NNT→Clinical role of brexpiprazole in depression and schizophrenia. https://t.co/AYeEaqVgBO
Clinical role of brexpiprazole in depression and schizophrenia – Dove Medical Press https://t.co/61h2D0Xy6N https://t.co/jdt7Epw0GV